Inotec
healthtech · Cambridge, GB
Wound-care company developing continuous topical oxygen therapy (NATROX O2).
Funding history
| Date | Round | Amount |
|---|
| Dec 2024 | Series C Cambridge-based Inotec raised 33M USD Series C led by Amadeus Capital Partners to secure US reimbursement for its NATROX O2 wound therapy. | $33M |
Investors
Amadeus Capital PartnersMeltwindPuhua CapitalThe Wealth Club
Similar companies in healthtech
Explore funding flow on EquityFlow →